|
1 Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi, 1967，16(3) ：178-222.
|
|
2 Taubert KA, Rowley AH, Shulman ST. Nationwide survey ofKawasaki disease and acute rheumatic fever. J Pediatr，1991，119(2):279-282.
|
|
3 Yanagawa H, Yashiro M, Nakamura Y, et al. Results of 12nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med, 1995，149(7) ：779-783.
|
|
4 Bronstein DE，Besser RE，Burns JC. Passive surveillance forKawasaki disease in San Diego County. Pediatr Infect Dis J ,1997，16(11):1015-1018.
|
|
5 Furusho K，Kamiya T，Nakano H，et al. High-dose intravenousgammaglobulin for Kawasaki disease. Lancet, 1984，2 (8411):1055-1058.
|
|
6 Kato H, Koike S，Yokoyama T. Kawasaki disease ：effect oftreatment on coronary artery involvement. Pediatrics, 1979，63(2):175-179.
|
|
7 Kato H，Ichinose E. Therapy of Kawasaki disease in the acutephase：steroid and aspirin therapy. Jpn Pediatr，1983，41(9):2092-2096.
|
|
8 Jadad AR，Cook DJ，Jones A，et al. Methodology and reports of systematic reviews and meta-analyses ：a comparison of Cochrane reviews with articles published in paper-based journals. JAMA,1998，15(280):278-280.
|
|
9 Egger M, Smith GD, Phillips AN. Meta-analysis ：principles and procedures. BMJ, 1997，315(7121) ：1533-1537.
|
|
10 Kanoko H，Masahiro I，Motofumi I，et al. Re-treatment for immune-globulin resistant Kawasaki disease ：a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int, 2001, 43(3):211-217.
|
|
11 袁渝，李桂玲，孟姜华等.皮质激素治疗川崎病25例近期疗效分析.中国实用儿科杂志，2000，15(1)：49.
|
|
12 Toshio A, Katsunori T, Sanji K, et al. Follow-up data of prospective controlled study for the treatment，clinical sign and laboratory data of Kawasaki disease. Pediatrics J, 1986，90(8):1844-1849.
|
|
13 Sanji K, Katsunori T. A prospective study for treatment ofKawasaki disease with 3 regimens ：aspirin，flubiprofen，predonisolone + dipyridamole. J Jpn Pediatr Soc, 1983，87(12)：2486-2491.
|
|
14 Sanji K, Katsunori T. Studies on treatment of Kawasaki disease during acute stage. J Jpn Pediatr Soc, 1985，89(4)：814-818.
|
|
15 Sanji K, Katsunori T. A randomized controlled study of three different therapies for patients having Kawasaki disease. J Jpn Pediatr Soc，1986，90(8) ：1844-1849.
|
|
16 Shiro S, Takeshi M, Takao H, et al. Acontrolled trial of steroid pulse therapy for Kawasaki disease ：part 1. J Jpn Pediatr Soc,1983，87(3):399-406.
|
|
17 Toshio N. Studies on activated platelets in Kawasaki disease. J Jpn Pediatr Soc, 1985，89(8) ：1845-1860.
|
|
18 Nonaka Y, Usui N, Eto Y, et al. Are patients with Kawasaki disease not respond IVGG therapy treated with super large amount of gamma-globulin? Prog Med, 2000, 20(7) ：1430-1434.
|
|
19 Kijima Y，Kamiya T, Suzuki A, et al. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J，1982，46(11):1239-1242.
|
|
20 Kijima Y. Effect of methylprednisolone administrations for patients with Kawasaki disease to prevent coronary aneurysm formation in the acute stage. J Osaka Med College, 1983，42(3-4):313-320.
|
|
21 Shiro S, Kuniaki O, Takeshi M, et al. A controlled trial of steroid pulse therapy for Kawasaki disease ：part 2. J Jpn Pediatr Soc, 1984, 88(6):1234-1240.
|
|
22 Kamiya T. Progress in treatment for Kawasaki disease. Recent Adv Cardiovasc Dis, 1989，10(2) ：170-176.
|
|
23 Dahlem PG, von Rosenstiel IA, Lam J, et al. Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease. Intensive Care Med，1999，25(10):1137-1139.
|
|
24 Dale RC，Saleem MA, Daw S，et al. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr, 2000,137(5)：723-726.
|
|
25 Kelly PC, Pearl WR，Weir MR. Infantile polyarteritis nodosa with mucocutaneous lymph node syndrome treated with long-term corticosteroids. South Med J, 1987,80(8) ：1045-1048.
|
|
26 Newburger JW. Treatment of Kawasaki disease ：corticosteroids revisited. J Pediatr,1999,135(4) ：411-413.
|
|
27 Shulman ST, Rowley AH. Treatment of Kawasaki disease with corticosteroid. J Pediatr, 1996,128(1)：146-149.
|
|
28 Shinohara M, Sone K, Kobayashi T, et al. Treatment ofKawasaki disease with corticosteroid. J Pediatr, 1996，129(3):483-484.
|
|
29 Han RK, Silverman ED, Newman A, et al. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med, 2000 Jul, 154(7) ：694-699.
|
|
30 Wallace CA, French JW, Kahn SJ, et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatr,2000,105(6):E78.
|
|
31 Raman V，Kim J, Sharkey A, et al. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatr Infect Dis J,2001,20(6) : 635-637.
|
|
32 Wright DA, Newburger JW，Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr, 1996,128(1) ：146-149.
|
|
33 Makota S, Katsuhiko S，Takeshi T, et al. Corticosteroids in thetreatment of the acute phase of Kawasaki disease. J Pediatr，1999，135:465-469.
|